67 related articles for article (PubMed ID: 1714137)
1. RUDER: interim evaluation of a 2-year, multicentre study of risk factors for duodenal ulcer relapse.
Armstrong D; Blum AL; Arnold R; Classen M; Goebell H; Fischer M
Z Gastroenterol Verh; 1991 Mar; 26():171-2. PubMed ID: 1714137
[No Abstract] [Full Text] [Related]
2. Smoking as a risk factor for duodenal ulcer relapse. RUDER Study Group.
Breuer-Katschinski BD; Armstrong D; Goebell H; Arnold R; Classen M; Fischer M; Blum AL
Z Gastroenterol; 1995 Sep; 33(9):509-12. PubMed ID: 8525653
[TBL] [Abstract][Full Text] [Related]
3. [A single evening dose of 300 mg ranitidine in the treatment of acute attacks of gastric and duodenal ulcers. Evaluation of 1,208 patients].
Bories P; Tournade JM; Alberola B; Pappo M
Ann Gastroenterol Hepatol (Paris); 1988 Oct; 24(5):227-32. PubMed ID: 3061358
[TBL] [Abstract][Full Text] [Related]
4. Does smoking predispose to peptic ulcer relapse after eradication of Helicobacter pylori?
Chan FK; Sung JJ; Lee YT; Leung WK; Chan LY; Yung MY; Chung SC
Am J Gastroenterol; 1997 Mar; 92(3):442-5. PubMed ID: 9068465
[TBL] [Abstract][Full Text] [Related]
5. The efficacy and safety of long-term maintenance treatment of duodenal ulcers with ranitidine.
Penston JG
Scand J Gastroenterol Suppl; 1990; 177():1-103. PubMed ID: 2263887
[No Abstract] [Full Text] [Related]
6. The efficacy and tolerability of famotidine and ranitidine on the healing of active duodenal ulcer and during six-month maintenance treatment, with special reference to NSAID/aspirin-related ulcers.
Bank S; Greenberg RE; Magier D; Lavin PT
Clin Ther; 1991; 13(2):304-18. PubMed ID: 1863945
[TBL] [Abstract][Full Text] [Related]
7. Bedtime administration of lansoprazole does not modify its greater efficacy vs ranitidine in the acute and long-term treatment of duodenal ulcer. Results from a multicentre, randomised, double blind clinical trial.
Russo A; Dattilo M
Ital J Gastroenterol Hepatol; 1997 Aug; 29(4):312-9. PubMed ID: 9476183
[TBL] [Abstract][Full Text] [Related]
8. Five-year maintenance treatment with ranitidine: effects on the natural history of duodenal ulcer disease.
Susi D; Neri M; Ballone E; Mezzetti A; Cuccurullo F
Am J Gastroenterol; 1994 Jan; 89(1):26-32. PubMed ID: 8273793
[TBL] [Abstract][Full Text] [Related]
9. Misoprostol and ranitidine in the prevention of NSAID-induced ulcers: a prospective, double-blind, multicenter study.
Raskin JB; White RH; Jaszewski R; Korsten MA; Schubert TT; Fort JG
Am J Gastroenterol; 1996 Feb; 91(2):223-7. PubMed ID: 8607484
[TBL] [Abstract][Full Text] [Related]
10. [Duodenal ulcer: comparison of 3 different long-term therapeutic protocols after healing].
Tafner G; De Berardinis F
Minerva Dietol Gastroenterol; 1987; 33(1):49-52. PubMed ID: 3587692
[No Abstract] [Full Text] [Related]
11. Early evening ranitidine administration promotes faster duodenal ulcer healing.
Merki H; Witzel L; Hüttemann W; Ansari A; Panijel M; Harre K; Heim J; Wolbergs E; Neumann HJ; Röhmel J
Am J Gastroenterol; 1988 Apr; 83(4):362-4. PubMed ID: 3279756
[TBL] [Abstract][Full Text] [Related]
12. [Long-term treatment of duodenal ulcer or healing of duodenal ulcerous disease?].
Mazure PA
Acta Gastroenterol Latinoam; 1995; 25(1):21-30. PubMed ID: 7660723
[No Abstract] [Full Text] [Related]
13. Prospective multicentre study of risk factors associated with delayed healing of recurrent duodenal ulcers (RUDER). RUDER Study Group.
Armstrong D; Arnold R; Classen M; Fischer M; Goebell H; Blum AL
Gut; 1993 Oct; 34(10):1319-26. PubMed ID: 8244095
[TBL] [Abstract][Full Text] [Related]
14. RUDER--a prospective, two-year, multicenter study of risk factors for duodenal ulcer relapse during maintenance therapy with ranitidine. RUDER Study Group.
Armstrong D; Arnold R; Classen M; Fischer M; Goebell H; Schepp W; Blum AL
Dig Dis Sci; 1994 Jul; 39(7):1425-33. PubMed ID: 8026252
[TBL] [Abstract][Full Text] [Related]
15. Influence of stress on the healing and relapse of duodenal ulcers. A prospective, multicenter trial of 2109 patients with recurrent duodenal ulceration treated with ranitidine. RUDER Study Group.
Holtmann G; Armstrong D; Pöppel E; Bauerfeind A; Goebell H; Arnold R; Classen M; Witzel L; Fischer M; Heinisch M
Scand J Gastroenterol; 1992 Nov; 27(11):917-23. PubMed ID: 1455188
[TBL] [Abstract][Full Text] [Related]
16. Effect of triple therapy or amoxycillin plus omeprazole or amoxycillin plus tinidazole plus omeprazole on duodenal ulcer healing, eradication of Helicobacter pylori, and prevention of ulcer relapse over a 1-year follow-up period: a prospective, randomized, controlled study.
Saberi-Firoozi M; Massarrat S; Zare S; Fattahi M; Javan A; Etaati H; Dehbashi N
Am J Gastroenterol; 1995 Sep; 90(9):1419-23. PubMed ID: 7661161
[TBL] [Abstract][Full Text] [Related]
17. [Long-term maintenance therapy in duodenal ulcer. Efficacy and safety].
Penston J; Wormsley KG
Fortschr Med; 1990 May; 108(14):282-6. PubMed ID: 2373457
[TBL] [Abstract][Full Text] [Related]
18. A comparative therapeutic trial of sucralfate and ranitidine in initial healing and relapse rate of duodenal ulcer.
Agrawal BK; Prasad RN; Kumar P
J Assoc Physicians India; 1990 Sep; 38 Suppl 1():720-2. PubMed ID: 2092028
[TBL] [Abstract][Full Text] [Related]
19. [Ranitidine therapy of duodenal ulcer: comparison of once-a-day and twice-a-day administration. A Swiss multicenter double-blind study].
Aenishänslin W; Bergoz R; Capitaine Y; Egger G; Etienne A; Fumagalli I; Güller R; Hammer B; Kobler E; Leuthold E
Schweiz Med Wochenschr; 1986 May; 116(19):637-41. PubMed ID: 3715441
[TBL] [Abstract][Full Text] [Related]
20. [Development and relapse of gastroduodenal ulcer in patients taking nonsteroid anti-inflammatory drugs: effects of standard risk factors].
Karateev AE; Nasonova VA
Ter Arkh; 2008; 80(5):62-6. PubMed ID: 18590118
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
